GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CVR Medical Corp (STU:B3BN) » Definitions » Debt-to-Equity

CVR Medical (STU:B3BN) Debt-to-Equity : -0.18 (As of Sep. 2022)


View and export this data going back to 2016. Start your Free Trial

What is CVR Medical Debt-to-Equity?

CVR Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was €0.61 Mil. CVR Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was €0.28 Mil. CVR Medical's Total Stockholders Equity for the quarter that ended in Sep. 2022 was €-4.86 Mil. CVR Medical's debt to equity for the quarter that ended in Sep. 2022 was -0.18.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for CVR Medical's Debt-to-Equity or its related term are showing as below:

STU:B3BN's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.21
* Ranked among companies with meaningful Debt-to-Equity only.

CVR Medical Debt-to-Equity Historical Data

The historical data trend for CVR Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVR Medical Debt-to-Equity Chart

CVR Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.13 -0.07 -0.23 -0.17

CVR Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.17 -0.18 -0.18 -0.18

Competitive Comparison of CVR Medical's Debt-to-Equity

For the Medical Devices subindustry, CVR Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVR Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CVR Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CVR Medical's Debt-to-Equity falls into.



CVR Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CVR Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as

CVR Medical's Debt to Equity Ratio for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CVR Medical  (STU:B3BN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


CVR Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CVR Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


CVR Medical (STU:B3BN) Business Description

Traded in Other Exchanges
N/A
Address
221 West Esplanade, c/o Suite 409, North Vancouver, Vancouver, BC, CAN, V7M 3J3
CVR Medical Corp is a medical device company. The company commercializing its Carotid Stenotic Scan (CSS), a patented, diagnostic tool that utilizes subsonic, infrasonic, and low-frequency sound wave analysis technology to detect and measure carotid arterial stenosis.

CVR Medical (STU:B3BN) Headlines

No Headlines